View in EDS HTML Full Text PDF Full Text

Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ.

Saved in:
Bibliographic Details
Title: Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ.
Authors: Benčurová K; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria., Balber T; Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria. theresa.balber@meduniwien.ac.at.; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Level 3L, Waehringer Guertel 18-20, 1090, Vienna, Austria. theresa.balber@meduniwien.ac.at., Weissenböck V; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Kogler L; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; CBmed GmbH-Center for Biomarker Research in Medicine, Graz, Austria., Friske J; Division of Molecular and Structural Preclinical Imaging, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Pichler V; Division of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria., Mitterhauser M; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria.; Department for Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria., Hacker M; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Philippe C; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria., Ozenil M; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Source: EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2025 Jan 10; Vol. 10 (1), pp. 1. Date of Electronic Publication: 2025 Jan 10.
Publication Type: Journal Article
Journal Info: Publisher: Springer Open Country of Publication: England NLM ID: 101714628 Publication Model: Electronic Cited Medium: Internet ISSN: 2365-421X (Electronic) Linking ISSN: 2365421X NLM ISO Abbreviation: EJNMMI Radiopharm Chem Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39792304
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical evaluation of the potential PARP-imaging probe [carbonyl-<superscript>11</superscript>C]DPQ.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Benčurová+K%22">Benčurová K</searchLink>; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Balber+T%22">Balber T</searchLink>; Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria. theresa.balber@meduniwien.ac.at.; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Level 3L, Waehringer Guertel 18-20, 1090, Vienna, Austria. theresa.balber@meduniwien.ac.at.<br /><searchLink fieldCode="AU" term="%22Weissenböck+V%22">Weissenböck V</searchLink>; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kogler+L%22">Kogler L</searchLink>; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; CBmed GmbH-Center for Biomarker Research in Medicine, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Friske+J%22">Friske J</searchLink>; Division of Molecular and Structural Preclinical Imaging, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Pichler+V%22">Pichler V</searchLink>; Division of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Mitterhauser+M%22">Mitterhauser M</searchLink>; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria.; Department for Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Hacker+M%22">Hacker M</searchLink>; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Philippe+C%22">Philippe C</searchLink>; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Ozenil+M%22">Ozenil M</searchLink>; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101714628%22">EJNMMI radiopharmacy and chemistry</searchLink> [EJNMMI Radiopharm Chem] 2025 Jan 10; Vol. 10 (1), pp. 1. <i>Date of Electronic Publication: </i>2025 Jan 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Open%22">Springer Open </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101714628 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2365-421X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222365421X%22">2365421X </searchLink><i>NLM ISO Abbreviation: </i>EJNMMI Radiopharm Chem <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39792304
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s41181-024-00323-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Benčurová K
      – PersonEntity:
          Name:
            NameFull: Balber T
      – PersonEntity:
          Name:
            NameFull: Weissenböck V
      – PersonEntity:
          Name:
            NameFull: Kogler L
      – PersonEntity:
          Name:
            NameFull: Friske J
      – PersonEntity:
          Name:
            NameFull: Pichler V
      – PersonEntity:
          Name:
            NameFull: Mitterhauser M
      – PersonEntity:
          Name:
            NameFull: Hacker M
      – PersonEntity:
          Name:
            NameFull: Philippe C
      – PersonEntity:
          Name:
            NameFull: Ozenil M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 01
              Text: 2025 Jan 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2365-421X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: EJNMMI radiopharmacy and chemistry
              Type: main
ResultId 1